0001628280-26-033836
SEC filingDucommun delivered 7.7% revenue growth and expanded gross margin to 26.9% in Q1 FY2026, supported by higher manufacturing volume and favorable product mix — though operating and net income declined modestly year-over-year.
Operating income declined 5.2% to $15.7M and net income fell 5.7% to $9.9M. Diluted EPS decreased 7.2% to $0.64, consistent with the net income result and the weighted-average shares outstanding disclosed in the financial statements. The filing does not characterize the drivers of the operating income decline beyond the segment-level gain noted above; therefore, no unsupported inference about SG&A or other expense categories is included. All income statement metrics are reported on a GAAP basis and reconciled to the XBRL source.
Capital expenditures totaled $2.9M in Q1 FY2026, down from $4.8M in Q1 FY2025. Free cash flow — defined as net cash provided by operating activities less capital expenditures — was $8.3M. This reflects continued discipline in capital allocation, with no disclosure in the authoritative packet suggesting strategic shifts, one-time investments, or changes in depreciation policy.